Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.37775 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.26468 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.36016 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.4123 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.21655 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.40084 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.3522 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.33542 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.40937 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.4517 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.72289 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.39857 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.35823 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.34913 | 70 |